4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)

Clinical trial NCT04517149 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04517149
Sponsor: 4D Molecular Therapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

X-Linked Retinitis Pigmentosa

Start date: 2020-06-09
Primary completion: 2026-06-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.